Stereotactic radiosurgery (SRS) and stereotactic ablative body radiotherapy (SABR) are advancing precision oncology by delivering highly accurate, high-dose radiation that achieves strong local ...

A new study conducted by researchers at Queen Elizabeth Hospital Birmingham in Birmingham, Great Britain, evaluated outcomes and toxicity associated with stereotactic radiotherapy in patients with ...

Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...

October 7, 2009 — Patients with brain metastases who were treated with whole-brain radiation therapy in addition to stereotactic radiosurgery were found to be at greater risk for cognitive decline, ...

A systematic review spanning two decades and 538 publications found that stereotactic radiosurgery demonstrated a median radiographic control rate of 82% in patients with metastatic brain tumors and a ...

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical research collaboration to evaluate precision radiomodulation therapy for ...

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...

In patients with renal cell carcinoma, a phase 2 trial tested neoadjuvant stereotactic ablative radiation therapy to the inferior vena cava tumor thrombus before radical nephrectomy with thrombectomy.

Researchers detailed a rare case linking delayed hematoma to cyst formation years after stereotactic radiosurgery for ...

The Cancer Center at University of Maryland Shore Regional Health has appointed Dr. Ashraf Youssef as medical director of the Requard Radiation Oncology Center.